Technology Transfer Office

Overview

The NIMH Technology Transfer Office (TTO) is committed to furthering the Institute's tradition of scientific excellence by working closely with investigators to facilitate the development of novel NIMH discoveries that have the potential to improve public health.

NIMH TTO facilitates collaborations by negotiating a variety of agreements with external organizations, including other federal laboratories, state and local governments, universities, and pharmaceutical and biotechnology companies. Among these agreements are Material Transfer Agreements (MTAs) for the exchange of research materials, Cooperative Research and Developments Agreements (CRADAs) for collaborative research endeavors, Clinical Trial Agreements (CTAs) for the conduct of preclinical and clinical studies in human subjects, and Confidential Disclosure Agreements (CDAs) for the exchange of confidential information.

To promote translational research and commercialization of NIMH technologies, the office carefully monitors, evaluates, and manages NIMH’s invention portfolio. Beginning with rigorous review of Employee Invention Reports (EIRs), the office manages patent prosecution of NIMH technologies, plays an active role in marketing these technologies to outside parties, works to license inventions to commercial partners, and oversees the distribution of royalties to NIMH inventors.

Staff

Jennifer Wong, M.S.
Ph: 301-828-7307
wongje@mail.nih.gov

Anton Dawson, Ph.D.
Ph: 301-339-3200
anton.dawson@nih.gov

Inez Fields
Ph: 240-593-6901
inez.fields@nih.gov

To learn more about NIH licensing opportunities, including NIMH technologies, please see: 
NIH Technology Transfer